A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy

[1]  D. Yeshurun,et al.  Thromboembolism in cancer. Changing trends , 1993, Cancer.

[2]  J. V. Sørensen,et al.  Venous thromboembolism and cancer. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[3]  S. Dawson,et al.  The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. , 1992, Atherosclerosis.

[4]  R. Gray,et al.  Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Carney,et al.  Thromboembolism. A complication of weekly chemotherapy in the treatment of non‐Hodgkin's lymphoma , 1990, Cancer.

[6]  R. Ádány,et al.  Factors of the Extrinsic Pathway of Blood Coagulation in Tumour Associated Macrophages , 1989, Thrombosis and Haemostasis.

[7]  L. Norton,et al.  Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. , 1989, The American journal of medicine.

[8]  S. Feffer,et al.  Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5‐fluorouracil , 1989, Cancer.

[9]  C. Redmond,et al.  A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. , 1989, The New England journal of medicine.

[10]  P. Callas,et al.  The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. , 1989, Blood.

[11]  M. Auger,et al.  Effects of tamoxifen on blood coagulation , 1988, Cancer.

[12]  J. Hirsh,et al.  The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. , 1988, The New England journal of medicine.

[13]  F. Cozzolino,et al.  Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. , 1988, The American journal of medicine.

[14]  J. Fontana,et al.  Chemotherapy for breast cancer decreases plasma protein C and protein S. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R. Fisher,et al.  Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  H. Dvorak.  Thrombosis and cancer. , 1987, Human pathology.

[17]  P. Bruzzi,et al.  Hypercoagulable state induced by cytostatic drugs in stage ii breast cancer patients , 1986, Cancer.

[18]  A. Falanga,et al.  Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue. , 1985, Biochemistry.

[19]  R. M. Vazquez,et al.  Thromboembolic complications associated with L‐asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma , 1985, Cancer.

[20]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[21]  C. Esmon,et al.  Familial protein S deficiency is associated with recurrent thrombosis. , 1984, The Journal of clinical investigation.

[22]  T. Barbui,et al.  L-Asparaginase Lowers Protein C Antigen , 1984, Thrombosis and Haemostasis.

[23]  H. Saito,et al.  Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five‐drug chemotherapy regimen , 1984, Cancer.

[24]  R. Enck,et al.  Tamoxifen treatment of metastatic breast cancer and antithrombin III levels , 1984, Cancer.

[25]  J. Griffin,et al.  Plasma protein S deficiency in familial thrombotic disease. , 1984, Blood.

[26]  F. Rickles,et al.  Activation of blood coagulation in cancer: Trousseau's syndrome revisited. , 1983, Blood.

[27]  F. Rickles,et al.  Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. , 1981, The Journal of laboratory and clinical medicine.

[28]  J. Griffin,et al.  Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.

[29]  R. Weiss,et al.  Venous thrombosis during multimodal treatment of primary breast carcinoma. , 1981, Cancer treatment reports.

[30]  E. Vellenga,et al.  ANTITHROMBIN III DEFICIENCY DURING ASPARAGINASE THERAPY , 1980, The Lancet.

[31]  R L Bick,et al.  Alterations of Hemostasis Associated With Malignancy: Etiology, Pathophysiology, Diagnosis and Management , 2008, Seminars in thrombosis and hemostasis.

[32]  A. Clauss,et al.  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .

[33]  A. Clauss.  [Rapid physiological coagulation method in determination of fibrinogen]. , 1957, Acta haematologica.

[34]  N. Fowler.  Thromboembolism , 1950 .

[35]  A. Trousseau.  Phlegmasia alba dolens. , 1865 .